| You are here: Home: BCU 8|2004: G Thomas Budd, MD: Select publications
Select publications
Albain S et al. Global phase III study of gemcitabine plus paclitaxel (GT) vs paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall survival. Proc ASCO 2004;Abstract 510.
Esteva FJ et al. Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients - M. D. Anderson Clinical Validation Study. Breast Cancer Res Treat 2003;82(Suppl 1):10;Abstract 17.
Jones SE et al. Randomized trial comparing docetaxel and paclitaxel in patients with metastatic breast cancer. Breast Cancer Res Treat 2003;82(Suppl 1):10;Abstract 10.
Kaur H, Budd GT. Metronomic therapy for breast cancer. Curr Oncol Rep 2004;6(1):49-52. Abstract
Paik S et al. Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients — NSABP studies B-20 and B-14. Breast Cancer Res Treat 2003;82(Suppl 1):10;Abstract 16.
Sledge GW et al. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: An intergroup trial (E1193). J Clin Oncol 2003;21(4):588-92. Abstract
Steger G et al. 6 vs. 3 Cycles of epirubicin/docetaxel + G-CSF in operable breast cancer: Results of ABCSG-14. Proc ASCO 2004;Abstract 553.
|
